Lake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)
I'm LongbridgeAI, I can summarize articles.
Lake Street analyst Mark Smith has reaffirmed a Buy rating for Achieve Life Sciences (ACHV) with a price target of $11.00. Smith, a 4-star analyst with a 44.29% success rate, indicates a Strong Buy consensus for ACHV, which has an average price target of $13.20 according to analysts. He also covers other stocks in the Consumer Cyclical sector.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments